Ardelyx (ARDX) Treasury Shares (2015 - 2026)
Ardelyx (ARDX) reported Treasury Shares of $15.9 million for Q1 2026, up 12.93% on a YoY basis from $14.1 million in Q1 2025, and up 26.62% quarter-over-quarter from $12.6 million in Q4 2025.
Ardelyx (ARDX) Treasury Shares (2015 - 2026) Analysis & Trends
Ardelyx has reported Treasury Shares for 12 years, with the latest figure at $15.9 million in Q1 2026.
- For the quarter ending Q1 2026, Treasury Shares rose 12.93% year-over-year to $15.9 million; the trailing twelve-month figure through Mar 2026 stood at $15.9 million (up 12.93% YoY), and the FY2025 full-year result was $12.6 million, up 57.03% from the prior year.
- Treasury Shares for Q1 2026 stood at $15.9 million, up from $12.6 million in the prior quarter.
- The five-year high for Treasury Shares was $15.9 million in Q1 2026, with the low at $1.4 million in Q4 2022.
- Historically, Treasury Shares has averaged $6.8 million across 5 years, with a median of $6.2 million in 2022.
- Annual changes were most pronounced in 2022 — Treasury Shares plunged 60.16% — and 2024, when it soared 183.37%.
- Ardelyx's Treasury Shares stood at $1.4 million in 2022, then soared by 159.32% to $3.6 million in 2023, then surged by 119.78% to $8.0 million in 2024, then jumped by 57.03% to $12.6 million in 2025, then climbed by 26.62% to $15.9 million in 2026.
- The last three Treasury Shares figures came in at $15.9 million (Q1 2026), $12.6 million (Q4 2025), and $13.0 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ardelyx | 1.49 Bn | 1.25 Bn | 89.66 Mn | 15.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.93 Mn |
| Mar 31, 2026 | 15.93 Mn |
| Dec 31, 2025 | 12.58 Mn |
| Dec 31, 2025 | 12.58 Mn |
| Jun 30, 2025 | 12.98 Mn |
| Jun 30, 2025 | 12.98 Mn |
| Mar 31, 2025 | 14.11 Mn |
| Mar 31, 2025 | 14.11 Mn |
| Dec 31, 2024 | 8.01 Mn |
| Dec 31, 2024 | 8.01 Mn |
| Sep 30, 2024 | 8.28 Mn |
| Sep 30, 2024 | 8.28 Mn |
| Jun 30, 2024 | 7.97 Mn |
| Jun 30, 2024 | 7.97 Mn |
| Mar 31, 2024 | 7.94 Mn |
| Mar 31, 2024 | 7.94 Mn |
| Dec 31, 2023 | 3.65 Mn |
| Dec 31, 2023 | 3.65 Mn |
| Sep 30, 2023 | 2.92 Mn |
| Sep 30, 2023 | 2.92 Mn |